Answers are grounded in this paper and cite their sources.
Introduction Littoral cell angioma (LCA) is a rare vascular tumor of the spleen that is mostly benign but has malignant potential. Differentiating between these forms is challenging and relies on surgical pathology for final diagnosis, with splenectomy serving as both a diagnostic and curative measure. As metastatic LCA is exceedingly rare, limited data on treatment and follow-up is available in the existing literature. Methods A retrospective review of LCA cases treated at our institution from 2000 to 2023 was conducted. A comprehensive literature review was also performed to assess treatment options, long-term follow-up, and prognosis for malignant LCA. Results The cohort included six patients, with a mean age of 67 years. Two-thirds of cases were incidentally diagnosed. Five patients underwent splenectomy. Pathological examination revealed splenomegaly in two-thirds of the cohort. One patient developed liver and retroperitoneal metastases six years post-splenectomy. Pazopanib was chosen as the first-line treatment following consultation with a multidisciplinary team. After six months of daily Pazopanib, the patient exhibited reduced lymphadenopathy and stable disease in the liver. A literature review identified seven cases of metastatic LCA, predominantly focusing on diagnosis and revealing a gap in information on treatment regimens, follow-up strategies, and prognosis. Conclusion LCA presents significant diagnostic and therapeutic challenges, particularly in metastatic cases. For those, these findings suggest the need for extended follow-up beyond the conventional five-year cancer benchmark and individualized treatment approaches. Reporting metastatic and other complex LCA cases is crucial for enhancing the literature and guiding healthcare providers in managing this rare disease.
No takes yet. Share an insight, caveat, or question.
Blades et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: